Insiders Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:27 2025-06-13 am EDT			5-day change	1st Jan Change
318.00 ^EUR	-0.31%		-2.30%	+0.47%

Apr. 16	VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway
Apr. 16	VIRBAC : Stifel still buying after Q1 results	CF

Insiders

French and Benelux stocks-Factors to watch	Apr. 16	RE
VIRBAC : Oddo BHF remains 'neutral', confirms its target	Mar. 17	CF
French and Benelux stocks-Factors to watch	Mar. 14	RE
Virbac Announces CEO Changes	24-09-13	CI
Virbac CEO to Step Down; Interim Successor Named	24-07-08	MT
Virbac appoints new CEO and raises sales growth target	24-07-08	RE
Virbac Sa Announces Chief Executive Officer Changes	24-07-08	CI
Biote Appoints Robert Peterson as CFO	24-01-11	MT
Virbac Announces Board Changes	17-06-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Virbac: Decent Q1; Clarity on US tariff exposure was a key takeaway

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway

April 16, 2025 at 07:58 am EDT